A research team led by the Fisabio Foundation has discovered that dermcidin, an antimicrobial peptide naturally produced by the human body, exhibits antiviral activity against the influenza virus, according to findings published in the Proceedings of the National Academy of Sciences. The research demonstrates that people who do not develop flu-like symptoms have higher baseline levels of dermcidin, suggesting that elevated dermcidin levels could be associated with lower susceptibility to influenza infection. This discovery reveals a previously unknown role for dermcidin beyond its established antimicrobial function and may help explain why some individuals are naturally more resistant to influenza than others.
Dermcidin's Dual Antimicrobial and Antiviral Properties
- ▪A research team led by the Fisabio Foundation demonstrated that dermcidin exhibits antiviral activity against the influenza virus
- ▪Dermcidin exhibits antiviral activity against the influenza virus
- ▪The Fisabio Foundation research team's findings on dermcidin are published in the journal Proceedings of the National Academy of Sciences
- ▪Dermcidin is an antimicrobial peptide produced constitutively by the human body
Correlation Between Dermcidin Levels and Flu Susceptibility
- ▪People who do not develop flu-like symptoms have higher baseline levels of dermcidin
- ▪Higher baseline levels of dermcidin could be associated with lower susceptibility to influenza infection
Perspective of Fisabio Foundation research team
- ▪Dermcidin's natural production by the human body makes it a potential biomarker for predicting influenza susceptibility
- ▪The discovery of dermcidin's antiviral properties represents a new understanding of innate immune defenses against influenza
Story comments
Loading comments…